CLENE INC

Clene Inc. harnesses nanotech to develop oral neurotherapeutics, targeting neurodegenerative diseases while navigating market swings and R&D challenges.

Clene Inc., a clinical-stage biopharmaceutical company, has navigated a tumultuous journey in the development of innovative therapeutics for neurodegenerative diseases, marked by significant stock fluctuations and regulatory challenges.